LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Spectral Medical Inc.
Headquarters:
Toronto, ON, Canada
Website:
http://www.spectraldx.com
Year Founded:
1991
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Chris Seto, MBA
Number Of Employees:
29
Enterprise Value:
$93,584,809
PE Ratio:
-6.14
Exchange/Ticker 1:
TSX:EDT
Exchange/Ticker 2:
OTCQB:EDTXF
Latest Market Cap:
$110,681,065
BioCentury
|
Oct 18, 2017
Company News
Management tracks: Gilead, Ipsen, Depomed
Read More
BioCentury
|
Jan 6, 2017
Clinical News
Toraymyxin: Ph III EUPHRATES data
Read More
BioCentury
|
Jan 6, 2017
Finance
Tiers of disappointment
Bad year for biotech ends on sour note in 4Q16 with all market cap tiers in red
Read More
BioCentury
|
Jul 11, 2016
Company News
Spectral Medical sales and marketing update
Read More
BioCentury
|
Jun 27, 2016
Clinical News
Toraymyxin: Completed Phase III enrollment
Read More
BioCentury
|
Feb 29, 2016
Financial News
Spectral Medical financial update
Read More
BioCentury
|
Feb 22, 2016
Financial News
Spectral Medical completes follow-on
Read More
BioCentury
|
Feb 1, 2016
Financial News
Spectral Medical proposes follow-on
Read More
BioCentury
|
Mar 23, 2015
Financial News
Spectral Medical completes private placement
Read More
BioCentury
|
Mar 23, 2015
Clinical News
Toraymyxin: Phase III ongoing
Read More
Items per page:
10
1 - 10 of 10
Help Center
Username
Request a Demo
Request Training
Ask a Question
Elevio by Dixa
Help